Defense Advanced Research Projects AgencyTagged Content List

Opportunities for Funding and/or Engagement

Relating to potential relationships with DARPA

Showing 4 results for Opportunities + Therapy RSS
11/06/2014
Many businesses and academic researchers wishing to pursue cutting-edge research ideas with government support lack the resources to navigate the burdensome paperwork requirements required to win federal grants or contracts. DARPA’s Biological Technologies Office (BTO) has created a simplified proposal process to attract and fund new ideas from just those types of innovators—those operating at the intersection of biology and technology who may never have worked with the Defense Department and may otherwise have remained too daunted to try.
May 17, 2019,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day meeting to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes.
11/19/2019
Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the military are particularly impactful because options for treating them are limited. No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions. Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability. Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.
01/22/2020
The Bridging the Gap Plus (BG+) program will develop new approaches to treating spinal cord injury by developing systems that address acute injury stabilization regenerative therapy as well as chronic functional restoration.